Piyasa bakış

The global ophthalmoscopes market is experiencing steady growth, with a valuation of USD 53.02 million in 2021 and an expected reach of USD 73.90 million by 2027, growing at a CAGR of 5.69%. Ophthalmoscopy, performed using ophthalmoscope devices, is a crucial part of eye examinations used to assess the vitreous humor, optic disc, and retina. It is instrumental in detecting retinal vascular diseases such as glaucoma, katarakt, diyabetik retinopati, ve yaşa bağlı makula dejenerasyonu. Ophthalmoscopy plays a vital role in routinely monitoring diabetic retinopathy in patients with diabetes mellitus.

The increasing prevalence of eye diseases is driving the demand for eye testing equipment. Globally, there are approximately 596 million people suffering from distance vision impairment, with 43 million being blind. Etrafında 510 million individuals have uncorrected near vision impairment, predominantly in low-middle-income countries. By 2050, it is projected that 895 million people will have distance vision impairment, with 61 million being blind. This growing target population presents significant growth opportunities in the market.

Indirect laser ophthalmoscopy, smartphone-based indirect ophthalmoscopes, and vision boost technology are revolutionizing the industry. The expanding application of ophthalmoscopes in other medical fields, such as neurology and headache treatment, will create new opportunities in the future.

Manufacturers are actively promoting awareness of ophthalmoscope technology advancements, driving market expansion. bunlara ek olarak, increasing healthcare expenditures for the treatment of vision loss and sight-threatening disorders fuel the demand for primary eye care and examinations, thereby increasing the need for crucial equipment like ophthalmoscopes. The rising prevalence of eye diseases further drives the demand for eye examinations and ophthalmoscopy for conditions such as cataracts, glokom, diyabetik retinopati, ve yaşa bağlı makula dejenerasyonu.

The accessibility of eye care services in developed countries, coupled with the increasing prevalence of eye conditions, has contributed to the higher application rate of ophthalmoscopes. The global burden of vision impairment is substantial, with untreated myopia and presbyopia alone resulting in estimated annual productivity losses of USD 244 billion and USD 25.4 milyar, sırasıyla.

Sonuç olarak, the global ophthalmoscopes market is poised for growth due to technological advancements, increasing awareness, and the rising incidence of eye diseases. With the expanding target population and demand for eye care services, the market is expected to reach USD 73.90 million by 2027.

Pazar Segmentasyonu

Pazar çeşitli faktörlere göre bölümlere ayrılmıştır, including type, indication, son kullanıcı, ve coğrafya.

Segmentation by Type
Direct
Indirect

Segmentation by Indication
Glokom
Diabetic Retinopathy
Yaşa bağlı makula dejenerasyonu
Retinal Detachment
Other

Segmentation by End-User
Göz Klinikleri & Hastaneler
Ophthalmologist & Optometrist
Ambulatory Surgical Centres

Coğrafyaya Göre Segmentasyon
Kuzey Amerika – BİZ, Kanada
Avrupa – Almanya, Fransa, İngiltere, İtalya, ispanya
Asya Pasifik – Çin, Japonya, Hindistan, Güney Kore, Avustralya
Latin Amerika – Brezilya, Meksika, Arjantin
Orta Doğu & Afrika – Güney Afrika, Suudi Arabistan, Türkiye

The Ophthalmoscopes market is divided into two segments: direct and indirect ophthalmoscopes. Some of the major manufacturers of direct ophthalmoscopes include Welch Allyn, Nidek Inc, Heine USA Ltd., US ophthalmic, Honsun Group, Iridex Şirketi, Oscar Boscarlol S.r.l., Zumax Medical Co. Ltd., Rudolf Riester GmbH, Dino-Lite Europe, and Medline Industries Inc. İçinde 2021, direct ophthalmoscopes held a prime position in the industry, bir şey için hesaplamak 60.16% of the market share.

Leading manufacturers of indirect ophthalmoscopes include Nidek Co. A.Ş., Ellex Medical Laser Ltd, Carl Zeiss, Ziemer Ophthalmic System Ag, Keeler Ltd, Heine Optotechnik GmbH, Topcon Medical Laser System, Iridex Şirketi, Lumenis Ltd, ve diğerleri. The presence of these players with a wide range of product portfolios creates a dynamic nature within the industry. The high number of market players and their global distribution channels contribute to the growth of the market.

The indication market is segmented based on various eye diseases such as glaucoma, diyabetik retinopati, retinal detachment, age-related macular degeneration, katarakt, macular pucker, corneal opacities, trachoetc ma, presbyopia, myopia, astigmatism, peripheral neovascularization, lattice degeneration, vesaire. İçinde 2021, the glaucoma segment dominated the market with a 31.81% Pazar payı. Other significant indications include diabetic retinopathy (23.37% Pazar payı), age-related macular degeneration (18.03% Pazar payı), and retinal detachment (5.27% Pazar payı).

The end-user segment comprises eye clinics and hospitals, ophthalmologists and optometrists, and ambulatory surgical centers. The presence of eye clinics and hospitals drives the high application rate of ophthalmoscopes for eye testing, bir şey için hesaplamak 52.34% market share in 2021. Ophthalmologists, optometrists, and ambulatory surgical centers account for 32.80% Ve 14.86% industry share, sırasıyla. Ambulatory surgical centers are widely accepted in eye care services, contributing to the overall growth of the industry.

North America has widespread availability of eye care services, leading to a high application rate of ophthalmoscope medical devices. Factors such as the high prevalence of eye conditions, better access to eye examinations, and increased awareness drive the market in this region, which accounted for a 38.82% share in 2021. Europe follows closely with a 32.89% Pazar payı, experiencing steady growth in ophthalmoscope use due to an increasing frequency of diabetic retinopathy, glokom, and cataracts.

The APAC region is notable for its high prevalence of diabetes, which drives the use of ophthalmoscopes for identifying diabetic retinopathy. bunlara ek olarak, the dense and aging population in the region positively influences market growth, accounting for a 20.23% Pazar payı. Latin America is an emerging market with increasing eye care expenditure, a growing patient population, and rising demand for eye care services, representing a 5.04% market share in 2021. Orta Doğu & Africa present significant growth opportunities, driven by a large population suffering from glaucoma, diyabetik retinopati, and blindness, as well as increasing government initiatives. İçinde 2021, Orta Doğu & Africa accounted for a 3.01% market share in the global ophthalmoscope market.

Rekabetçi Ortam

İçinde 2021, Heine launched the Omega600, a new indirect ophthalmoscope that brought significant changes to the market. This product incorporates vision boost technology, which enhances illumination and improves the clinician’s ability to assess conditions such as cataracts and vitreous opacities in patients.

According to a 2021 report in the BMJ journal, smartphone ophthalmoscopy technology has potential applications beyond ophthalmology in the context of the COVID-19 era. Smartphone ophthalmoscopes have generally been preferred over traditional direct ophthalmoscopes due to their shorter handling time. These devices enable practitioners to conduct examinations and view the fundus remotely, providing the advantage of long-distance working compared to conventional ophthalmoscopes.

İçinde 2021, the Hillrom company introduced the Welch Allyn PanOptic Plus Ophthalmoscope devices, which offer a viewing area that is 20 times larger than standard ophthalmoscopes. This advancement provides clinicians with an expanded field of view for enhanced examination and diagnosis.

Key companies profiled in this report include Heine USA Ltd, Dino Lite Avrupa, Iridex Şirketi, Halma, Nidek Co. Ltd., Oscar Boscarol S.r.l, Rudolf Riester GmbH, ABD Oftalmik, Albert Waeschle, American Diagnostic Corporation, Shanghai Bolan Optical Electric Co Ltd, Carl Zeiss, Ellex, Essilor Uluslararası (Essilor Instruments USA), Heidelberg Mühendisliği, Invotech Excel, Medline Industries LP, Neitz Instruments Co Ltd, Suzhou Kangjie Tıp A.Ş., Spengler, Topcon Co. Ltd., Lumenis, Zumax Medikal, 66 Vizyon Teknolojisi, Zhejiang Honsun Tıp Teknolojileri A.Ş.. Ltd..

Cevaplanan Anahtar Sorular

HOW LARGE IS THE OPHTHALMOSCOPES MARKET?

The global ophthalmoscopes market had a valuation of USD 53.02 million in 2021 and is anticipated to reach USD 73.90 million by 2027, exhibiting a CAGR of 5.69%.

WHAT ARE THE RECENT TRENDS IN THE OPHTHALMOSCOPES MARKET?

The latest market trends in the ophthalmoscopes market involve technological advancements and new applications of ophthalmoscopy.

WHO ARE THE MAIN PLAYERS IN THE OPHTHALMOSCOPES MARKET?

The key players in the ophthalmoscopes market include Heine USA Ltd, Dino-Lite Europe, Iridex Şirketi, Nidek Co. Ltd., Oscar Boscarol S.r.l, Rudolf Riester GmbH, and US Ophthalmic.

WHAT ARE THE FACTORS CONTRIBUTING TO THE GROWTH OF THE OPHTHALMOSCOPES MARKET?

Factors such as increased awareness among the patient population, expanding eye care services in developed countries, and the prevalence of eye disorders along with surgical procedures are driving the growth of the ophthalmoscopes market.

WHICH END-USER SEGMENT WILL HOLD THE LARGEST SHARE IN THE OPHTHALMOSCOPE MARKET BY 2027?

By 2027, eye clinics and hospitals are expected to hold the largest share in the ophthalmoscope end-user segment.